Last reviewed · How we verify

NCT06318351

Transcutaneous Acupoint Electrical Stimulation and Postoperative Delirium Delirium

Recruiting now Last updated 9 April 2024
What this trial tests

trial testing transcutaneous acupoint electrical stimulation in Delirium, Postoperative in 476 participants. Currently enrolling.

Timeline
1 February 2024
Primary endpoint
30 December 2024
30 August 2025

Quick facts

Lead sponsorQin Zhang
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment476
Start date1 February 2024
Primary completion30 December 2024
Estimated completion30 August 2025
Sites2 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Qin Zhang

Who can join

18 and older, any sex, with Delirium, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigating postoperative delirium in patients undergoing thoracoscopic lung resection surgery who have received or not received relevant transcutaneous acupoint electrical stimulation treatment preoperatively, observing postoperative recovery quality indicators, evaluating the necessity of treatment, and clarifying the potential mechanisms by which transcutaneous acupoint electrical stimulation may improve postoperative delirium.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of transcutaneous acupoint electrical stimulation

Trials testing the same drug.

Other recruiting trials for Delirium, Postoperative

Currently open trials in the same condition.

Other Qin Zhang trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06318351.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing